Product Images Astagraf Xl

Description: This text appears to show a comparison of the effects of drugs on the pharmacokinetics of Tacrolimus, specifically in relation to Astagraf XL. The drugs compared are ketoconazole and rifampin, with different dosing regimens. The text mentions Cmax and AUC values, as well as a geometric mean ratio and 90% confidence interval. However, due to the fragmented nature of the text, it is difficult to provide a more detailed description.*

This is a report on the pharmacokinetics of co-administered drugs with tacrolimus. The report includes information on the Cmax and AUC of several drugs including telapravi, boceprevir, magnesium hydroxide, voriconazole, and posaconazole. The report also provides Geometric Mean Ratio of Test to Reference and 90% CI for tacrolimus immediate release alone and with co-administered drugs.*

This appears to be a medication label for the drug Astagraf XL® (tacrolimus extended-release capsules) which is available for daily use with a dosage warning. The label also mentions a Varnish-free area requirement for printing the LOT, EXP, and something that appears to be "Proatatsspm Soa Fcksga". There are 30 capsules in the container.*

This is a label or packaging description for the pharmaceutical product Astagraf XL. It describes the product as "tacrolimus extended-release capsules" to be used for the printing of lot, EXP and serialization information. The dosage and the form of the drug are provided. The label also indicates the number of capsules per package.*

This text appears to be a label of medication called Astagraf XL, which comes in the form of extended-release capsules that contain tacrolimus. The label specifies some important information such as the dosage regimen (once-daily), prescriptions restrictions (RxOnly), and serialization information. However, the text does not provide any further details regarding the medication's indications, efficacy, safety or side effects.*